外来うつ病患者における服薬アドヒアランスへの影響要因に関する実証研究 薬局利用患者の服薬支援の観点から
Saved in:
| Published in | 医薬品情報学 Vol. 24; no. 1; pp. 17 - 29 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | Japanese |
| Published |
一般社団法人 日本医薬品情報学会
31.05.2022
|
| Online Access | Get full text |
| ISSN | 1345-1464 1883-423X |
| DOI | 10.11256/jjdi.24.17 |
Cover
| Author | 熊谷, 純 櫻井, 秀彦 |
|---|---|
| Author_xml | – sequence: 1 fullname: 櫻井, 秀彦 organization: 北海道科学大学薬学部薬学科社会薬学部門薬事管理学分野 – sequence: 1 fullname: 熊谷, 純 organization: 北海道科学大学薬学部薬学科社会薬学部門薬事管理学分野 |
| BookMark | eNo9UMtKw0AAXETBWnvyO1Kzu8lme_AgxRcUvCh4C5vsRhtqlaYXb25KBRUPilREpaVWsSgFEURB8WOWtOlfGKs4h5lhYOYwU2C8vFMWAMxAPQshMsms7_NiFhlZaI2BFKQUawbCG-OJx4apQYMYkyATBL6egEBsQpQCXtRp9G_ulDxQsjO4qPfD23i_ruSjkkdKnqrwuH99EjeeVNhWtUNVOxuZrqq9qPBdyTcle9Hn87D5Fd_L6KqVFIeNtpKXSTHqNeOHj0HrfNB9nQYTHisFIvOnabC-uLCWX9YKq0sr-fmC5iNCTc3hDBPmYE6w6VJBc4g7rkuo8Ijj6Cyn65QLxzI83cJEGJSjHOScCW5ZrmtZFKfB3O-uH1TZprB3K8VtVtmzWaVadEvC_rnIRoYNR2T95-4Wq9g-w9-rHoed |
| ContentType | Journal Article |
| Copyright | 2022 日本医薬品情報学会 |
| Copyright_xml | – notice: 2022 日本医薬品情報学会 |
| DOI | 10.11256/jjdi.24.17 |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1883-423X |
| EndPage | 29 |
| ExternalDocumentID | article_jjdi_24_1_24_17_article_char_ja |
| GroupedDBID | ABJNI ACGFS ALMA_UNASSIGNED_HOLDINGS JSF KQ8 RJT |
| ID | FETCH-LOGICAL-j2685-bda36ab3d635c8e892dbcc68ef6bb0a9008deb74f0736e48d291ddaed77cc7783 |
| ISSN | 1345-1464 |
| IngestDate | Wed Sep 03 06:31:13 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | 1 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j2685-bda36ab3d635c8e892dbcc68ef6bb0a9008deb74f0736e48d291ddaed77cc7783 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jjdi/24/1/24_17/_article/-char/ja |
| PageCount | 13 |
| ParticipantIDs | jstage_primary_article_jjdi_24_1_24_17_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2022/05/31 |
| PublicationDateYYYYMMDD | 2022-05-31 |
| PublicationDate_xml | – month: 05 year: 2022 text: 2022/05/31 day: 31 |
| PublicationDecade | 2020 |
| PublicationTitle | 医薬品情報学 |
| PublicationTitleAlternate | 医薬品情報学 |
| PublicationYear | 2022 |
| Publisher | 一般社団法人 日本医薬品情報学会 |
| Publisher_xml | – name: 一般社団法人 日本医薬品情報学会 |
| References | 7) 上島国利．うつ病患者の治療薬に対する期待と現状．臨床精神薬理 2009；12：967-74 17) Srimongkon P, Aslani P, Chen TF. Consumer-related factors influencing antidepressant adherence in unipolar depression: a qualitative study. Patient Preference Adherence 2018; 12: 1863-73. 27) Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence and long-term predictive validity of blood pressure control. Med Care 1986; 24:67-74. 22) Jiang X, Wang J, Lu Y, et al. Self-efficacy-focused education in persons with diabetes: a systematic review and meta-analysis. Psychol Res Behav Manag 2019; 12:67-79. 9) 福岡勝志，平野良真，少林正彦．抗うつ薬のアドヒアランスにおける薬局薬剤師の積極的な服薬指導の効果― 第 2 報介入終了後のフォローアップ―．Therapeut Res 2013；34：659-64. 69) Okereke OI, Cook NR, Albert CM, et al. Effect of long-term supplementation with folic acid and B vitamins on risk of depression in older women. Br J Psychiat 2015; 206: 324-31. 51) 染谷文洋，詫間浩樹，泉澤 恵ら．患者の薬剤師への相談ニーズ．YAKUGAKU ZASSHI 2009；129：1137-40. 33) Murray A. The implementation of a self‐administration of medication programmes within older persons mental health. J Psychiat Mental Health Nursing 2011; 18: 113-21. 29) 山西 裕，大森祐作，山西奈帆ら．統合失調症患者における処方薬自己管理の有用性．医療薬学 2008；34：1097-99. 31) De las Cuevas C, de Leon J. Self-report for measuring and predicting medication adherence: experts’ experience in predicting adherence in stable psychiatric outpatients and in pharmacokinetics. Patient Preference Adherence 2020; 14: 1823-42. 66) 岸本桂子，利谷正浩，大岩眞二ら．うつ病患者に対する薬局薬剤師の応対に関与する要因の検討．医療薬学 2016；42：795-808. 36) 櫻井秀彦．医薬分業制度における知覚サービス品質の評価構造に関するモデル分析．生活経済学研究 2019；49：1-14. 60) 小山内康徳，櫻井秀彦．薬局における健康相談業務の有用性に関する検討．医療薬学 2019；45：312-21. 34) Jang S, Cho H, Kang C. Antidepressant adherence and its predictors in immigrants with depression: a population-based study. Medicine 2020; 99:1-9. 50) Buus N, Johannessen H, Stage KB. Explanatory models of depression and treatment adherence to antidepressant medication: a qualitative interview study. Intern J Nursing Stud 2012; 49: 1220-9. 40) 日本うつ病学会，“日本うつ病学会治療ガイドライン Ⅱ．大うつ病性障害（最新版：2016 年 7 月 31 日）”， https://www.secretariat.ne.jp/jsmd/iinkai/katsudou/data/20190724-02.pdf（2021 年 8 月 11 日閲覧） 19) De las Cuevas C, Peñate W, Sanz EJ. The relationship of psychological reactance, health locus of control and sense of self-efficacy with adherence to treatment in psychiatric outpatients with depression. BMC Psychiat 2014; 14: 324. 59) 櫻井秀彦，吉町昌子，早瀬幸俊．プロフェッショナル・サービス提供組織に対する品質評価構造に関する実証研究―保険薬局を対象として―．流通研究 2011；13：5-17. 58) Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equat Model: A Multidiscipl J 1999: 6; 1-55. 25) del Pino-Sedeño T, Peñate W, De las Cuevas C, et al. Effectiveness and cost-effectiveness of a multicomponent intervention to improve medication adherence in people with depressive disorders-mapdep: a study protocol for a cluster randomized controlled trial. Patient Preference Adherence 2019; 13: 309-19. 41) 梅林佑有，岡崎幸恵，延山宗能ら．わが国における，うつ病患者，うつ病寛解者およびうつ病患者家族を対象とした診療実態ならびに寛解に影響する要因の調査． Therapeut Res 2020；41：25-39. 67) Karp JF, Kincman J, Lightfoot M, et al. A systematic review of community pharmacy initiatives to improve treatment of depression and pain: focus on types of programs and patient-reported outcomes. Res Soc Adm Pharm 2022; 18: 2569-78. 32) Boczkowski JA, Zeichner A, DeSanto N. Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. J Consult Clin Psychol 1985; 53: 666-71. 70) Serna MC, Cruz I, Real J, et al. Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database. Eur Psychiat 2010; 25: 206-13. 48) Hunot VM, Horne R, Leese MN, et al. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Primary Care Companion to the J Clin Psychiat 2007; 9:91-9. 16) Mey A, Knox K, Kelly F, et al. Trust and safe spaces: mental health consumers' and carers' relationships with community pharmacy staff. Patient-Patient-Centered Outcomes Res 2013; 6: 281-9. 23) 櫻井秀彦，恩田光子，野呂瀬崇彦ら．医薬分業下における外来慢性疾患患者の服薬アドヒアランスと医療サービス評価の関連性：残薬削減とかかりつけ薬局を志向した実証研究．社会薬学 2016；35：23-33. 4) 齋藤百枝美．精神科医療における服薬アドヒアランス向上とメンタルヘルスリテラシー教育．YAKUGAKU ZASSHI 2021；141：541-55. 14) Srimongkon P, Aslani P, Chen TF. A systematic review of measures of medication adherence in consumers with unipolar depression. Res Soc Adm Pharm 2019; 15:3-22. 54) Nunnally JC. Psychometric theory: 2nd ed: New York: McGraw-Hill, 1978. 38) Rubio-Valera M, Chen TF, O'Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Intern J Environ Res Publ Health 2014; 11: 10967-90. 68) Kjosavik SR, Gillam MH, Roughead EE. Average duration of treatment with antidepressants among concession card holders in Australia. Aust New Zealand J Psychiat 2016; 50: 1180-5. 52) 小山内康徳，木村礼志，高杉公彦ら．休日・夜間の薬局サービスに関するニーズの潜在的患者属性の探索と安心感の調査．社会薬学 2017；36：106-17. 28) Gabriel A, Violato C. Knowledge of and attitudes towards depression and adherence to treatment: The Antidepressant Adherence Scale (AAS). J Affect Disord 2010; 126: 388-94. 46) Brydges S, Rennick-Egglestone S, Anderson C. Men's views of antidepressant treatment for depression, and their implications for community pharmacy practice. Res Soc Adm Pharm 2020; 6: 1041-9. 37) Tamburrino MB, Nagel RW, Chahal MK, et al. Anti-depressant medication adherence: a study of primary care patients. Primary Care Companion to the J Clini Psychiat 2009; 11: 205-11. 26) 黒川淳一，永井典子，末続なつ江ら．精神疾患治療における服薬状況に関するアンケート調査．日本職業・災害医学会会誌 2013；61：382-92. 1) 厚生労働省ホームページ，“患者調査”，https://www.mhlw.go.jp/toukei/list/10-20-kekka_gaiyou.html（2021 年 7 月 1 日閲覧） 55) Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. (Hillsdale, NJ). Lawrence Earlbaum Associates, 1988. 5) 玉地亜衣，酒井 明，佐藤素子ら．精神科病院における患者の服薬アドヒアランス向上に向けた薬剤管理指導業務の構築．YAKUGAKU ZASSHI 2010；130：1565-72. 47) Burns DD, Nolen-Hoeksema S. Therapeutic empathy and recovery from depression in cognitive-behavioral therapy: a structural equation model. J Consul Clin Psychol 1992; 60:441-9. 20) De las Cuevas C, de Leon J, Peñate W, et al. Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach. Patient Preference Adherence 2017; 11: 681-90. 10) World Health Organization, “Adherence to long-term therapies: evidence for action, Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data. 2003,” http://www.who.int/chp/knowledge/publications/adherence_report/en/(accessed 1 July, 2021 65) 野田久美子，小田綾乃，櫻井秀彦．うつ病患者および抑うつ症状保有患者における薬局と薬剤師に対するニーズ分析．医療薬学 2019；45：301-11. 2) 岡島由佳．うつ病治療におけるアドヒアランス．臨床精神薬理 2008；11：1645-50. 71) Zmoira A, Rogers E, Johnson A, et al. Implementation of a depression screening as part of a holistic adherence assessment in a large community pharmacy chain. J Am Pharm Assoc 2021; 61: 154-60. 35) Nagai N, Tani H, Yoshida K, et al. Drug attitude, insight, and patient’s knowledge about prescribed antipsychotics in schizophrenia: a cross-sectional survey. Neuropsychiat Dis Treat 2020; 16: 781-7. 6) 岡井彰男，井門敬子，末丸克矢ら．精神科チーム医療における薬剤師の活動とイラストを導入した服薬指導の評価．医療薬学 2011；37：209-15. 53) 逸見孝広，菅井柚希，三浦裕幸ら．保険薬局における患者からの質問の傾向と課題：患者層の異なる 2 薬局のデータによる検証．社会薬学 2022；41（in press） 3) 菊池俊暁．服薬アドヒアランス不良なうつ病患者に対する工夫とは．臨床精神薬理 2013；16：1313-20. 24) 櫻井秀彦，岸本桂子，森藤ちひろ．意図的/非意図的中断に着目した服薬アドヒアランスの影響要因に関する実証研究．日本ファーマシューティカルコミュニケーション学会会誌 2018；16：4-12. 21) Nafradi L, Nakamoto K, Schulz PJ, Is patient empowerment the key to promote adherence ?. A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PloS one 2017; 12: e0186458. 30) Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983; 13: 177-83. 57) Hu LT, Bentler PM. Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychol Meth 1998; 3: 424-53. 49) Brook O, van Hout H, Nieuwenhuyse H, et al. Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. Eur Neuropsychopharmacol 2003; 13:1-9. 44) Srinivasan J, Cohen NL, Parikh SV. Patient attitudes regarding causes of depression: implications for psychoeducation. Can J Psychiat 2003; 48: 493-5. 8) 長谷川隆子，平野良真，武田泰昭ら．抗うつ薬のアドヒアランスにおける薬局薬剤師の積極的な服薬指導の効果．Therapeut Res 2012；33：1693-700. 12) Thompson L, McCabe R. The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiat 2012; 12:1-12. 39) 永江誠治，花田裕子．精神科看護における服薬アドヒアランス研究の現状と課題．保健学研究 2009；22：41-50. 13) Readdean KC, Heuer AJ, Parrott JS. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: a systematic review and meta-analysis. Res Soc Adm Pharm 2018; 14: 321-31. 18) Alekhya P, Sriharsha M, Priya DT, et al. Treatment and disease related factors affecting non-adherence among patients on long term therapy of antidepressants. J Depress Anxiety 2015; 4: 175-81. 64) 野田久美子，後藤奨一，櫻井秀彦．うつ病患者の薬局薬剤師に対する相談行動の実態とその妨害要因．社会薬学 2020；39：72-8. 42) Becker TE. Potential problems in the statistical control of variables in organizational research: a qualitative analysis with recommendations. Organizat Res Meth 2005; 8: 274-89. 62) McMillan SS, Kelly F, Hattingh HL, et al. The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes. J Mental Health 2018: 27; 164-73. 61) Rickles NM, Svarstad BL, Statz-Paynter JL, et al. Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. J Am Pharm Assoc 2005; 45: 344-53. 43) Bernerth JB, Aguinis H. A critical review and best-practice recommendations for control variable usage. Personnel Psychol 2016; 69: 229-83. 45) Latalova K, Kamaradova D, Prasko J. Perspectives on perceived stigma and self-stigma in adult male patients with depression. Neuropsychiat Dis Treat 2014; 10: 1399-40 |
| References_xml | – reference: 22) Jiang X, Wang J, Lu Y, et al. Self-efficacy-focused education in persons with diabetes: a systematic review and meta-analysis. Psychol Res Behav Manag 2019; 12:67-79. – reference: 54) Nunnally JC. Psychometric theory: 2nd ed: New York: McGraw-Hill, 1978. – reference: 15) Solmi M, Miola A, Croatto G, et al. How can we improve antidepressant adherence in the management of depression ?. A targeted review and 10 clinical recommendations. Brazil J Psychiat 2020; 43: 189-202. – reference: 55) Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. (Hillsdale, NJ). Lawrence Earlbaum Associates, 1988. – reference: 61) Rickles NM, Svarstad BL, Statz-Paynter JL, et al. Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. J Am Pharm Assoc 2005; 45: 344-53. – reference: 68) Kjosavik SR, Gillam MH, Roughead EE. Average duration of treatment with antidepressants among concession card holders in Australia. Aust New Zealand J Psychiat 2016; 50: 1180-5. – reference: 38) Rubio-Valera M, Chen TF, O'Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Intern J Environ Res Publ Health 2014; 11: 10967-90. – reference: 66) 岸本桂子，利谷正浩，大岩眞二ら．うつ病患者に対する薬局薬剤師の応対に関与する要因の検討．医療薬学 2016；42：795-808. – reference: 29) 山西 裕，大森祐作，山西奈帆ら．統合失調症患者における処方薬自己管理の有用性．医療薬学 2008；34：1097-99. – reference: 20) De las Cuevas C, de Leon J, Peñate W, et al. Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach. Patient Preference Adherence 2017; 11: 681-90. – reference: 44) Srinivasan J, Cohen NL, Parikh SV. Patient attitudes regarding causes of depression: implications for psychoeducation. Can J Psychiat 2003; 48: 493-5. – reference: 12) Thompson L, McCabe R. The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiat 2012; 12:1-12. – reference: 24) 櫻井秀彦，岸本桂子，森藤ちひろ．意図的/非意図的中断に着目した服薬アドヒアランスの影響要因に関する実証研究．日本ファーマシューティカルコミュニケーション学会会誌 2018；16：4-12. – reference: 32) Boczkowski JA, Zeichner A, DeSanto N. Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. J Consult Clin Psychol 1985; 53: 666-71. – reference: 5) 玉地亜衣，酒井 明，佐藤素子ら．精神科病院における患者の服薬アドヒアランス向上に向けた薬剤管理指導業務の構築．YAKUGAKU ZASSHI 2010；130：1565-72. – reference: 30) Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983; 13: 177-83. – reference: 8) 長谷川隆子，平野良真，武田泰昭ら．抗うつ薬のアドヒアランスにおける薬局薬剤師の積極的な服薬指導の効果．Therapeut Res 2012；33：1693-700. – reference: 21) Nafradi L, Nakamoto K, Schulz PJ, Is patient empowerment the key to promote adherence ?. A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PloS one 2017; 12: e0186458. – reference: 1) 厚生労働省ホームページ，“患者調査”，https://www.mhlw.go.jp/toukei/list/10-20-kekka_gaiyou.html（2021 年 7 月 1 日閲覧）． – reference: 60) 小山内康徳，櫻井秀彦．薬局における健康相談業務の有用性に関する検討．医療薬学 2019；45：312-21. – reference: 67) Karp JF, Kincman J, Lightfoot M, et al. A systematic review of community pharmacy initiatives to improve treatment of depression and pain: focus on types of programs and patient-reported outcomes. Res Soc Adm Pharm 2022; 18: 2569-78. – reference: 25) del Pino-Sedeño T, Peñate W, De las Cuevas C, et al. Effectiveness and cost-effectiveness of a multicomponent intervention to improve medication adherence in people with depressive disorders-mapdep: a study protocol for a cluster randomized controlled trial. Patient Preference Adherence 2019; 13: 309-19. – reference: 37) Tamburrino MB, Nagel RW, Chahal MK, et al. Anti-depressant medication adherence: a study of primary care patients. Primary Care Companion to the J Clini Psychiat 2009; 11: 205-11. – reference: 43) Bernerth JB, Aguinis H. A critical review and best-practice recommendations for control variable usage. Personnel Psychol 2016; 69: 229-83. – reference: 48) Hunot VM, Horne R, Leese MN, et al. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Primary Care Companion to the J Clin Psychiat 2007; 9:91-9. – reference: 4) 齋藤百枝美．精神科医療における服薬アドヒアランス向上とメンタルヘルスリテラシー教育．YAKUGAKU ZASSHI 2021；141：541-55. – reference: 27) Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence and long-term predictive validity of blood pressure control. Med Care 1986; 24:67-74. – reference: 45) Latalova K, Kamaradova D, Prasko J. Perspectives on perceived stigma and self-stigma in adult male patients with depression. Neuropsychiat Dis Treat 2014; 10: 1399-405. – reference: 40) 日本うつ病学会，“日本うつ病学会治療ガイドライン Ⅱ．大うつ病性障害（最新版：2016 年 7 月 31 日）”， https://www.secretariat.ne.jp/jsmd/iinkai/katsudou/data/20190724-02.pdf（2021 年 8 月 11 日閲覧）． – reference: 2) 岡島由佳．うつ病治療におけるアドヒアランス．臨床精神薬理 2008；11：1645-50. – reference: 42) Becker TE. Potential problems in the statistical control of variables in organizational research: a qualitative analysis with recommendations. Organizat Res Meth 2005; 8: 274-89. – reference: 39) 永江誠治，花田裕子．精神科看護における服薬アドヒアランス研究の現状と課題．保健学研究 2009；22：41-50. – reference: 9) 福岡勝志，平野良真，少林正彦．抗うつ薬のアドヒアランスにおける薬局薬剤師の積極的な服薬指導の効果― 第 2 報介入終了後のフォローアップ―．Therapeut Res 2013；34：659-64. – reference: 17) Srimongkon P, Aslani P, Chen TF. Consumer-related factors influencing antidepressant adherence in unipolar depression: a qualitative study. Patient Preference Adherence 2018; 12: 1863-73. – reference: 64) 野田久美子，後藤奨一，櫻井秀彦．うつ病患者の薬局薬剤師に対する相談行動の実態とその妨害要因．社会薬学 2020；39：72-8. – reference: 71) Zmoira A, Rogers E, Johnson A, et al. Implementation of a depression screening as part of a holistic adherence assessment in a large community pharmacy chain. J Am Pharm Assoc 2021; 61: 154-60. – reference: 49) Brook O, van Hout H, Nieuwenhuyse H, et al. Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. Eur Neuropsychopharmacol 2003; 13:1-9. – reference: 7) 上島国利．うつ病患者の治療薬に対する期待と現状．臨床精神薬理 2009；12：967-74． – reference: 31) De las Cuevas C, de Leon J. Self-report for measuring and predicting medication adherence: experts’ experience in predicting adherence in stable psychiatric outpatients and in pharmacokinetics. Patient Preference Adherence 2020; 14: 1823-42. – reference: 47) Burns DD, Nolen-Hoeksema S. Therapeutic empathy and recovery from depression in cognitive-behavioral therapy: a structural equation model. J Consul Clin Psychol 1992; 60:441-9. – reference: 6) 岡井彰男，井門敬子，末丸克矢ら．精神科チーム医療における薬剤師の活動とイラストを導入した服薬指導の評価．医療薬学 2011；37：209-15. – reference: 58) Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equat Model: A Multidiscipl J 1999: 6; 1-55. – reference: 46) Brydges S, Rennick-Egglestone S, Anderson C. Men's views of antidepressant treatment for depression, and their implications for community pharmacy practice. Res Soc Adm Pharm 2020; 6: 1041-9. – reference: 28) Gabriel A, Violato C. Knowledge of and attitudes towards depression and adherence to treatment: The Antidepressant Adherence Scale (AAS). J Affect Disord 2010; 126: 388-94. – reference: 41) 梅林佑有，岡崎幸恵，延山宗能ら．わが国における，うつ病患者，うつ病寛解者およびうつ病患者家族を対象とした診療実態ならびに寛解に影響する要因の調査． Therapeut Res 2020；41：25-39. – reference: 52) 小山内康徳，木村礼志，高杉公彦ら．休日・夜間の薬局サービスに関するニーズの潜在的患者属性の探索と安心感の調査．社会薬学 2017；36：106-17. – reference: 63) 田沼和紀，渡邉文之，前田初代ら．薬局薬剤師が心に寄り添う服薬支援をすることを目的とした認知行動療法的アプローチを用いた研修プログラムの開発と検証． YAKUGAKU ZASSHI 2017；137：227-40. – reference: 56) Field A. Discovering statistics using SPSS. 2nd ed: London: Sage Publications, 2005. – reference: 3) 菊池俊暁．服薬アドヒアランス不良なうつ病患者に対する工夫とは．臨床精神薬理 2013；16：1313-20. – reference: 33) Murray A. The implementation of a self‐administration of medication programmes within older persons mental health. J Psychiat Mental Health Nursing 2011; 18: 113-21. – reference: 11) Rubio-Valera M, Serrano-Blanco A, Magdalena-Belío J, et al. Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis. Annal Pharmacotherap 2011; 45:39-48. – reference: 14) Srimongkon P, Aslani P, Chen TF. A systematic review of measures of medication adherence in consumers with unipolar depression. Res Soc Adm Pharm 2019; 15:3-22. – reference: 70) Serna MC, Cruz I, Real J, et al. Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database. Eur Psychiat 2010; 25: 206-13. – reference: 26) 黒川淳一，永井典子，末続なつ江ら．精神疾患治療における服薬状況に関するアンケート調査．日本職業・災害医学会会誌 2013；61：382-92. – reference: 53) 逸見孝広，菅井柚希，三浦裕幸ら．保険薬局における患者からの質問の傾向と課題：患者層の異なる 2 薬局のデータによる検証．社会薬学 2022；41（in press） – reference: 57) Hu LT, Bentler PM. Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychol Meth 1998; 3: 424-53. – reference: 19) De las Cuevas C, Peñate W, Sanz EJ. The relationship of psychological reactance, health locus of control and sense of self-efficacy with adherence to treatment in psychiatric outpatients with depression. BMC Psychiat 2014; 14: 324. – reference: 50) Buus N, Johannessen H, Stage KB. Explanatory models of depression and treatment adherence to antidepressant medication: a qualitative interview study. Intern J Nursing Stud 2012; 49: 1220-9. – reference: 62) McMillan SS, Kelly F, Hattingh HL, et al. The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes. J Mental Health 2018: 27; 164-73. – reference: 13) Readdean KC, Heuer AJ, Parrott JS. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: a systematic review and meta-analysis. Res Soc Adm Pharm 2018; 14: 321-31. – reference: 65) 野田久美子，小田綾乃，櫻井秀彦．うつ病患者および抑うつ症状保有患者における薬局と薬剤師に対するニーズ分析．医療薬学 2019；45：301-11. – reference: 23) 櫻井秀彦，恩田光子，野呂瀬崇彦ら．医薬分業下における外来慢性疾患患者の服薬アドヒアランスと医療サービス評価の関連性：残薬削減とかかりつけ薬局を志向した実証研究．社会薬学 2016；35：23-33. – reference: 69) Okereke OI, Cook NR, Albert CM, et al. Effect of long-term supplementation with folic acid and B vitamins on risk of depression in older women. Br J Psychiat 2015; 206: 324-31. – reference: 10) World Health Organization, “Adherence to long-term therapies: evidence for action, Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data. 2003,” http://www.who.int/chp/knowledge/publications/adherence_report/en/(accessed 1 July, 2021) – reference: 34) Jang S, Cho H, Kang C. Antidepressant adherence and its predictors in immigrants with depression: a population-based study. Medicine 2020; 99:1-9. – reference: 36) 櫻井秀彦．医薬分業制度における知覚サービス品質の評価構造に関するモデル分析．生活経済学研究 2019；49：1-14. – reference: 59) 櫻井秀彦，吉町昌子，早瀬幸俊．プロフェッショナル・サービス提供組織に対する品質評価構造に関する実証研究―保険薬局を対象として―．流通研究 2011；13：5-17. – reference: 18) Alekhya P, Sriharsha M, Priya DT, et al. Treatment and disease related factors affecting non-adherence among patients on long term therapy of antidepressants. J Depress Anxiety 2015; 4: 175-81. – reference: 16) Mey A, Knox K, Kelly F, et al. Trust and safe spaces: mental health consumers' and carers' relationships with community pharmacy staff. Patient-Patient-Centered Outcomes Res 2013; 6: 281-9. – reference: 35) Nagai N, Tani H, Yoshida K, et al. Drug attitude, insight, and patient’s knowledge about prescribed antipsychotics in schizophrenia: a cross-sectional survey. Neuropsychiat Dis Treat 2020; 16: 781-7. – reference: 51) 染谷文洋，詫間浩樹，泉澤 恵ら．患者の薬剤師への相談ニーズ．YAKUGAKU ZASSHI 2009；129：1137-40. |
| SSID | ssj0000613512 ssib000994793 ssib031740806 |
| Score | 1.901626 |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 17 |
| Subtitle | 薬局利用患者の服薬支援の観点から |
| Title | 外来うつ病患者における服薬アドヒアランスへの影響要因に関する実証研究 |
| URI | https://www.jstage.jst.go.jp/article/jjdi/24/1/24_17/_article/-char/ja |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 医薬品情報学, 2022/05/31, Vol.24(1), pp.17-29 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1883-423X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000613512 issn: 1345-1464 databaseCode: KQ8 dateStart: 20090101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxRBEB5CBPEiPvFNDvZx4m5PTz-O3ZsJQYkgJJDbMq8F9xBFkosnZ0MEFQ-KREQlIUYxKAERREHxxwybbP6F1Y9JJuohCSxD091V9VXVNFXVdM963tUOyfNmjpmfJXrrJiOxz_OQ-U3cSZsQ0SFF1oXi5E06MU2uz4QzQ8NDtVNL83PJaHr_v_dKDuNV6AO_6luyB_DsDlPogDb4F57gYXjuy8coCpEkSFAUUSTGkAxRFEBuiDh1DRiNGBIM8VDP4RjJAEVcn2_g1WSpKirpGqJpGhhxZTi3EB_TVCBIttyQxKYBP-EaAv89JKshFbghJZwIxSvpkdZCjSEFQgUS40iNa1mS6lEYEgrJRg2qMDBwBVXUoIaam7DkHKmW1h1ohTECgFG0novr-byFlKqpBuIMW22rwJgo1ByUQSLBwjsbmXoKwNHUBCmJRKjfViOIafNaperzmXaLtjFAA5asmq_Ag6S--wKFuzs44NaLEWGcpl3HDVKmfauiykKBxgNmBhgWj7LObBgqql8BGTpnWkUPrrrh3EJC1iJZQEIfwqDFn9s-zgMf8ueZevizV9j3LHMby-ydWpcV2W2pf-MtZMw64Haz26OYjFYkez5g7pZHW09qY9JumgdrV_36emG7CzXOEcwo1f9CcuNWrUQQgtRiCKS7BIocurOPqvPR0B5qqDR213A1tmu7yCDF7ELBVR3WNPnj1AnvuCv8RqSFc9Ib6sanvKOT7mjLaa_TX1vafPu-LB6WxdrWy8XN3rvBg8Wy-FQWj8viWdl7svnm6WDpc9lbLRcelQvPTWO9XPha9n6Uxfey2Oj_-rK9_Hvwoei_XgHC7aXVsngFhP2N5cHHn1srL7bWv53xpsejqdaE7_4Exe9iykM_yeKAxkmQQWWQ8pwLnCVpSnneoUnSiAXk8FmeMNKBWE1zwjMsmlkW5xljacoYD856w7N3ZvNz3khM05AJHMcMclLSAKYpF80OCYJOHCYpPu9Ra6H2Xfulm_Y-XXfhsIQXvWO7i-qSNzx3bz6_DEn-XHLFvAV_APvT0zI |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%A4%96%E6%9D%A5%E3%81%86%E3%81%A4%E7%97%85%E6%82%A3%E8%80%85%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E6%9C%8D%E8%96%AC%E3%82%A2%E3%83%89%E3%83%92%E3%82%A2%E3%83%A9%E3%83%B3%E3%82%B9%E3%81%B8%E3%81%AE%E5%BD%B1%E9%9F%BF%E8%A6%81%E5%9B%A0%E3%81%AB%E9%96%A2%E3%81%99%E3%82%8B%E5%AE%9F%E8%A8%BC%E7%A0%94%E7%A9%B6&rft.jtitle=%E5%8C%BB%E8%96%AC%E5%93%81%E6%83%85%E5%A0%B1%E5%AD%A6&rft.au=%E6%AB%BB%E4%BA%95%2C+%E7%A7%80%E5%BD%A6&rft.au=%E7%86%8A%E8%B0%B7%2C+%E7%B4%94&rft.date=2022-05-31&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E3%80%80%E6%97%A5%E6%9C%AC%E5%8C%BB%E8%96%AC%E5%93%81%E6%83%85%E5%A0%B1%E5%AD%A6%E4%BC%9A&rft.issn=1345-1464&rft.eissn=1883-423X&rft.volume=24&rft.issue=1&rft.spage=17&rft.epage=29&rft_id=info:doi/10.11256%2Fjjdi.24.17&rft.externalDocID=article_jjdi_24_1_24_17_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1345-1464&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1345-1464&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1345-1464&client=summon |